|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2019
Cheson, Bruce D.; O'Brien, Susan; Ewer, Michael S.; Goncalves, Marcus D.; Farooki, Azeez; Lenz, Georg; Yu, Anthony; Fisher, Richard I.; Zinzani, Pierre L. und Dreyling, Martin
(2019):
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas.
In: Clinical Lymphoma Myeloma & Leukemia, Bd. 19, Nr. 3: S. 135-141
2017
Brown, Jennifer R.; Moslehi, Javid; O'Brien, Susan; Ghia, Paolo; Hillmen, Peter; Cymbalista, Florence; Shanafelt, Tait D.; Fraser, Graeme; Rule, Simon; Kipps, Thomas J.; Coutre, Steven; Dilhuydy, Marie-Sarah; Cramer, Paula; Tedeschi, Alessandra; Jäger, Ulrich; Dreyling, Martin; Byrd, John C.; Howes, Angela; Todd, Michael; Vermeulen, Jessica; James, Danelle F.; Clow, Fong; Styles, Lori; Valentino, Rudy; Wildgust, Mark; Mahler, Michelle und Burger, Jan A.
(2017):
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.
In: Haematologica, Bd. 102, Nr. 10: S. 1796-1805
1998
Munker, Reinhold; Kantarjian, Hagop; O'Brien, Susan; Keating, Michael; Andreeff, Michael und Estey, Elihu H.
(1998):
Phase I Study of Taxol in Refractory Acute Myelogenous Leukemias Using a Weekly Schedule.
In: Acta Haematologica, Nr. 2: S. 106-108
[PDF, 168kB]